Hope Discovered Here®

Creating a world without heart and vascular disease

We are the Minneapolis Heart Institute Foundation® (MHIF).

For more than 37 years, we’ve been a world-class cardiovascular research and education organization committed to making the impossible possible for our patients.

Patients are at the heart of our mission. We provide:

•Hope for patients, improving their well-being and life expectancy

•Hope for their children, siblings, parents and families

•Hope for new treatment options

•Hope for a world without heart and vascular disease

Learn More
Explore Our Centers

 

Center for Coronary Artery Disease

Valve Science Center

Penny Anderson Women’s Cardiovascular Center

Nolan Family Center for Cardiovascular Health

MHIF Physician-Initiated Research

Global Outreach

Benefits of Participating in Research

Every year, exciting breakthroughs and new discoveries stem from our research. These important findings advance medical knowledge, improving the health and lives of millions of people worldwide.

 

Be More Active

Take a more active role in your own health care.

Potential to Unlock More Options

You may gain access to investigational treatments and medications.

Make a Contribution

Help find new and better ways to treat people with your condition.

Find Clinical Research Trials

 

Our clinical research studies test new drugs, devices and medical procedures to improve care for future generations. View current research studies and see if you qualify to participate.

Read Our Latest News

Jessica Gottlieb: Congenital Heart Defect

Jessica Gottlieb: Congenital Heart Defect

In May 2019, Jessica Gottlieb and her husband Brent were eagerly looking forward to celebrating their fifth wedding anniversary. They’d had more than their share of heartbreak over the years, losing a baby girl on the day of her delivery in December of 2017 and then...

Minneapolis Heart Institute Foundation and UC-San Diego Receive FDA Approval of Investigational New Drug Application to Continue Research of Novel Hydrogel for Cardiac Tissue Repair

Minneapolis Heart Institute Foundation and UC-San Diego Receive FDA Approval of Investigational New Drug Application to Continue Research of Novel Hydrogel for Cardiac Tissue Repair

MHIF is conducting additional research on a novel hydrogel that is designed to repair cardiac tissue. In April 2020, the FDA approved an Investigational New Drug (IND) application to investigate the safety and feasibility of delivering VentriGel via catheter into areas of the heart of patients that cannot be completely revascularized at the time of coronary artery bypass grafting (CABG).

Join Us at Upcoming Events

Life After Stent

Life After Stent

  Have you or a loved one had angioplasty with or without stenting? If so, you may have questions about what comes next and what lifestyle adjustments you should make. Join the Minneapolis Heart Institute Foundation for an evening focusing on Life...

Sign up For Our Newsletter

Stay up to date on MHIF news, events and the latest information on heart disease treatment and prevention.